Chantix might not increase heart risk, review shows

Pfizer's smoking-cessation treatment Chantix might not increase the risk of heart attack and other serious heart conditions, as was reported in a 2011 study, according to a review that looked at data on 9,232 people treated for three months. Researcher Judith Prochaska said the first study was misleading because "findings were inflated, and they were just focusing on that relative risk." Only 0.63% of 5,431 individuals developed a serious heart problem.

View Full Article in:

Review finds Chantix may not raise heart risks - Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC